Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe

Oral Miltefosine for Indian Visceral Leishmaniasis

Shyam Sundar, T. K. Jha, C.P. Thakur et al. · New England Journal of Medicine · 2002 · 774 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection

H. Sindermann, Kirsten Engel, Christina Fischer et al. · Clinical Infectious Diseases · 2004 · 112 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Comparison of three treatment regimens with liposomal amphotericin B (AmBisome®) for visceral leishmaniasis in India: a randomized dose-finding study

C.P. Thakur, Avinash Pandey, Geeta Sinha et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1996 · 97 citations

Medicine, Infectious Diseases, Pharmacology +11

Visceral leishmaniasis in HIV infected patients: Treatment with high dose liposomal amphotericin B (AmBisome)

Roberta Russo, Luciano Nigro, S Minniti et al. · Journal of Infection · 1996 · 95 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +14

Post‐kala‐azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B

Roustan, GutiÉrrez‐Solar, Gallego et al. · British Journal of Dermatology · 1998 · 44 citations

Veterinary Medicine, Dermatology, Infectious Diseases +17